These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1578361

  • 61. DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects.
    Marasini B, Cugno M, Bassani C, Fabrizi I, Bottasso B, Agostoni A.
    Thromb Haemost; 1992 Nov 10; 68(5):621. PubMed ID: 1455411
    [No Abstract] [Full Text] [Related]

  • 62. Hypotension induced by vasopressin antagonists in rats: role of mast cell degranulation.
    Macia RA, Silver AC, Gabel RA, Campbell GK, Hanna N, DiMartino MJ.
    Toxicol Appl Pharmacol; 1990 Jan 10; 102(1):117-27. PubMed ID: 1688665
    [Abstract] [Full Text] [Related]

  • 63. Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor.
    Rehberg S, Enkhbaatar P, Rehberg J, La E, Ferdyan N, Qi S, Wisniewski K, Traber LD, Schteingart CD, Rivière PJ, Laporte R, Traber DL.
    Crit Care Med; 2012 Jun 10; 40(6):1957-60. PubMed ID: 22488005
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. DDAVP: does the drug have a direct effect on the vessel wall?
    Barnhart MI, Chen S, Lusher JM.
    Thromb Res; 1983 Jul 15; 31(2):239-53. PubMed ID: 6415852
    [Abstract] [Full Text] [Related]

  • 66. Effect of chlorobutanol and DDAVP on whole blood aggregation/clotting.
    Stewart MW, Gordon PA.
    Thromb Res; 1991 Dec 15; 64(6):757-62. PubMed ID: 1798965
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Effects of neurohypophyseal hormone analogues on blood clotting factor VIII and fibrinolytic activity in sheep.
    Neuenschwander S, Pliska V.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):205-13. PubMed ID: 9128840
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. DDAVP in uremia.
    Vicente V, Alberca I, Macias JF, Lopez Borrasca A.
    Nephron; 1984 Apr 04; 36(2):145-6. PubMed ID: 6420716
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Factor VIII-related activities after 1-deamino-8-D-arginine vasopressin in multicentric reticulohistiocytosis.
    Taddeo U, Trotta F, Menegale G, Ballerini G.
    Ric Clin Lab; 1984 Apr 04; 14(1):37-9. PubMed ID: 6427880
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Study of the mechanism of hemostatic effect of desmopressin.
    Zubairov DM, Andrushko IA, Zubairova LD, Svintenok GY.
    Bull Exp Biol Med; 2007 Aug 04; 144(2):200-2. PubMed ID: 18399279
    [Abstract] [Full Text] [Related]

  • 76. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
    Ripoll GV, Garona J, Pifano M, Farina HG, Gomez DE, Alonso DF.
    Breast Cancer Res Treat; 2013 Nov 04; 142(1):9-18. PubMed ID: 24122393
    [Abstract] [Full Text] [Related]

  • 77. Cardiovascular and hormonal responses to DDAVP before and after beta-blockade in patients with mild essential hypertension.
    Fallo F, Patrassi G, Girolami A, Castellano M, Beschi M, Mantero F.
    J Hypertens Suppl; 1988 Dec 04; 6(4):S675-7. PubMed ID: 3071598
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.